Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery | News
Search Refinements

Drug Delivery News

View news from other Pharmaceutical sectors:
151-165 of 2284 results
McKesson to buy Canadian drug store chain Rexall Health for $2.2bn
By PBR Staff Writer
McKesson has agreed to acquire Canadian pharmacy drug store chain Rexall Health from Katz Group for C$3bn ($2.2bn).
Drug Research > Drug Delivery > News
Savara Pharmaceuticals closes $20m Series C financing round
Savara Pharmaceuticals has closed a $20m Series C financing round.
Drug Research > Drug Delivery > News
FDA accepts Genentech's sBLA to extend indication of Xolair in allergic asthma to pediatric patients
The US Food and Drug Administration (FDA) has accepted for review Genentech's supplemental Biologics License Application (sBLA) to extend the indication of Xolair (omalizumab) in allergic asthma to pediatric patients.
Drug Research > Drug Delivery > News
FDA issues recommendations to reduce risk of Zika virus transmission by human cell and tissue products
As an additional safety measure against the emerging Zika virus outbreak, the U.S. Food and Drug Administration today issued new guidance for immediate implementation providing recommendations to reduce the potential transmission risk of Zika virus from human cells, tissues, and cellular and tissue-based products (HCT/Ps).
Drug Research > Drug Delivery > News
Concert Pharmaceuticals says CTP-656 solid dose phase 1 results confirmed superior pharmacokinetic profile to Kalydeco
Concert Pharmaceuticals announced new results from Part 1 of its multiple ascending dose Phase 1 clinical trial in which a single-dose tablet formulation of CTP-656 was compared to the commercial tablet formulation of Kalydeco, the current standard of care for cystic fibrosis patients with gating mutations
Drug Research > Drug Delivery > News
Retrophin secures European orphan drug designation for RE-024 to treat pantothenate kinase-associated neurodegeneration
The European Commission has granted orphan drug designation to RE-024, Retrophin's novel investigational phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration (PKAN), a rare and life-threatening genetic disorder with no approved treatment option.
Drug Research > Drug Delivery > News
AstraZeneca invests in US oral biologics firm Rani Therapeutics
By PBR Staff Writer
Anglo-Swedish pharma giant AstraZeneca has invested in the US-based oral biologics firm Rani Therapeutics.
Drug Research > Drug Delivery > News
Forty Seven completes first half of $75m financing round to target cancer-specific antibodies
By PBR Staff Writer
Clinical-stage immuno-oncology firm Forty Seven has completed the first half of a committed $75m Series A financing round.
Drug Research > Drug Delivery > News
Gordagen to trial new drug delivery technology from Monash University
Gordagen Pharmaceuticals, an Australian nutraceutical and pharmaceutical company, has signed a collaborative research agreement with Monash University to assess a new drug delivery technology.
Drug Research > Drug Delivery > News
Unilife partners with Amgen for injectable drug delivery systems
By PBR Staff Writer
Unilife has formed a collaboration with Amgen for injectable drug delivery systems centered on its portfolio of prefilled, customizable wearable injectors.
Drug Research > Drug Delivery > News
Biopharmaceutical firm Synlogic secures $40m financing
Synlogic has closed a Series B investment round with $40m in additional financing led by OrbiMed HealthCare Fund Management, bringing the total investment in its combined Series A and B financing to $70m.
Drug Research > Drug Delivery > News
ImmunID awarded Innovate UK grant to advance ImmunTraCkeR assay for therapeutic response prediction
ImmunID, the immune companion diagnostics for precision medicine company, has been awarded Small Business Research Initiative funding1 by Innovate UK, UK's innovation agency, to advance its ImmunTraCkeR assay for therapeutic response prediction.
Drug Research > Drug Delivery > News
ESSA Pharma reports financial results for first quarter
ESSA Pharma has reported financial results for the three months ended 31 December 2015.
Drug Research > Drug Delivery > News
Ennaid Therapeutics prioritizes Zika virus rapid drug development
Ennaid Therapeutics, located in Alpharetta, GA is developing therapeutic cures to help the millions of people worldwide when infected with the mosquito-borne disease, Zika Virus, now named a global public health emergency by the World Health Organization and the CDC.
Drug Research > Drug Delivery > News
Sandoz acquires European rights to Pfizer’s infliximab biosimilar
By PBR Staff Writer
Sandoz, the generic pharmaceuticals division of Novartis, has acquired rights to Pfizer’s PF-06438179, a biosimilar of Merck's Remicade (infliximab), in the 28-nation European Economic Area (EEA).
Drug Research > Drug Delivery > News
151-165 of 2284 results